$BOMO
bowmo, Inc. Stock $bomo

$bomo Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000121390023071846 Filed on August 30, 2023

Income Statement

Concept	2023 Q3	2023 Q2	2021
Revenue	$62.00K		$0.00
YoY Change
Cost Of Revenue			$51.64K
YoY Change
Gross Profit	$62.00K		$150.0K
YoY Change
Gross Profit Margin	100.0%
Selling, General & Admin	$309.9K	$165.1K	$502.8K
YoY Change	-13.76%	-47.93%	-24.47%
% of Gross Profit	499.81%		335.11%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$309.9K	$165.1K	$502.8K
YoY Change	-13.76%	-47.93%	-24.47%
Operating Profit	-$247.9K	-$165.1K	-$288.3K
YoY Change	-31.01%	-40.35%
Interest Expense	$169.4K	$227.9K	-$1.780M
YoY Change	-15.43%	497.39%	-27.35%
% of Operating Profit
Other Income/Expense, Net	-$749.6K	-$1.101M	$22.38K
YoY Change	274.28%	10592.33%
Pretax Income	-$997.4K	-$1.266M	-$1.553M
YoY Change	78.25%	341.03%	-28.89%
Income Tax
% Of Pretax Income
Net Earnings	-$997.4K	-$1.266M	-$1.553M
YoY Change	78.25%	341.03%	-28.89%
Net Earnings / Revenue	-1608.77%
Basic Earnings Per Share	$0.00	$0.00	$0.01
Diluted Earnings Per Share	$0.00	$0.00	-$322.80
COMMON SHARES
Basic Shares Outstanding	33.36B shares	31.30B	18.15M
Diluted Shares Outstanding	33.30M shares	32.27B shares	18.15M

Balance Sheet

Concept	2023 Q3	2023 Q2	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.870K	$77.75K	$5.710K
YoY Change	-95.93%	-72.7%
Cash & Equivalents	$3.868K	$77.75K	$5.710K
Short-Term Investments
Other Short-Term Assets	$860.00	$860.00
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$4.727K	$78.60K	$5.710K
YoY Change	-95.03%	-72.4%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00	$0.00	$0.00
YoY Change	-100.0%
TOTAL ASSETS
Total Short-Term Assets	$4.727K	$78.60K	$5.710K
Total Long-Term Assets	$0.00	$0.00	$0.00
Total Assets	$4.727K	$78.60K	$5.710K
YoY Change	-95.03%	-72.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$952.8K	$952.9K	$326.4K
YoY Change	128.36%	142.92%	0.0%
Accrued Expenses	$364.6K	$329.3K	$1.555M
YoY Change	-51.64%	-72.18%	7.74%
Deferred Revenue
YoY Change
Short-Term Debt	$896.4K	$775.1K	$864.1K
YoY Change	147.41%	170.83%	-47.5%
Long-Term Debt Due	$446.7K	$563.0K
YoY Change	73.69%	118.91%
Total Short-Term Liabilities	$6.854M	$6.017M	$2.971M
YoY Change	132.0%	79.7%	-46.51%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities			$0.00
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.854M	$6.017M	$2.971M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$6.854M	$6.017M	$2.971M
YoY Change	110.18%	64.61%	-46.51%
SHAREHOLDERS EQUITY
Retained Earnings	-$12.25M	-$9.892M
YoY Change	119.84%	97.27%
Common Stock	$333.6K	$324.4K
YoY Change	52.78%	107.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$773.5K	$773.5K
YoY Change	0.0%	0.0%
Treasury Stock Shares
Shareholders Equity	-$6.850M	-$5.938M	-$2.966M
YoY Change
Total Liabilities & Shareholders Equity	$4.727K	$78.60K	$5.710K
YoY Change	-95.03%	-72.4%

Cashflow Statement

Concept	2023 Q3	2023 Q2	2021
OPERATING ACTIVITIES
Net Income	-$997.4K	-$1.266M	-$1.553M
YoY Change	78.25%	341.03%	-28.89%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$46.58K	-$8.890K	-$65.29K
YoY Change	-83.78%	-93.28%	73.64%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions			$21.86K
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change		-100.0%
Cash From Investing Activities	$0.00	$0.00	$0.00
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-27.30K	-980.0	71.00K
YoY Change	-128.0%	-100.23%	88.83%
NET CHANGE
Cash From Operating Activities	-46.58K	-8.890K	-65.29K
Cash From Investing Activities	0.000	0.000	0.000
Cash From Financing Activities	-27.30K	-980.0	71.00K
Net Change In Cash	-73.88K	-9.870K
YoY Change	-61.06%	-103.43%
FREE CASH FLOW
Cash From Operating Activities	-$46.58K	-$8.890K	-$65.29K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-54624
	dei	Entity Registrant Name EntityRegistrantName	bowmo, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	WY
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-4144571
	dei	Entity Address Address Line1 EntityAddressAddressLine1	99 Wall Street
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 891
	dei	Entity Address City Or Town EntityAddressCityOrTown	New York City
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10005
	dei	City Area Code CityAreaCode	(212)
	dei	Local Phone Number LocalPhoneNumber	398-0002
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common stock
	dei	Trading Symbol TradingSymbol	BOMO
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	33360984221	shares
CY2023Q2	us-gaap	Cash Cash	77745	usd
CY2022Q4	us-gaap	Cash Cash	167103	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15542	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	858	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	858	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	78603	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	183503	usd
CY2023Q2	us-gaap	Assets Assets	78603	usd
CY2022Q4	us-gaap	Assets Assets	183503	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	952860	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	813378	usd
CY2023Q2	bomo	Accrued Expenses Current AccruedExpensesCurrent	200000	usd
CY2022Q4	bomo	Accrued Expenses Current AccruedExpensesCurrent	200286	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	329342	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	366622	usd
CY2023Q2	bomo	Accrued Officer Compensation AccruedOfficerCompensation	1207642	usd
CY2022Q4	bomo	Accrued Officer Compensation AccruedOfficerCompensation	1074361	usd
CY2023Q2	us-gaap	Loans Payable Current LoansPayableCurrent	308520	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	113006	usd
CY2023Q2	bomo	Loan Payable Related Party LoanPayableRelatedParty	254500	usd
CY2022Q4	bomo	Loan Payable Related Party LoanPayableRelatedParty	190500	usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	775141	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	669581	usd
CY2023Q2	bomo	Preferred Stocks Redemption Premium PreferredStocksRedemptionPremium	179684	usd
CY2022Q4	bomo	Preferred Stocks Redemption Premium PreferredStocksRedemptionPremium	219687	usd
CY2023Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1809399	usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	2172250	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	6017088	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5819671	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	260494	usd
CY2023Q2	us-gaap	Liabilities Liabilities	6017088	usd
CY2022Q4	us-gaap	Liabilities Liabilities	6080165	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32441177421	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32441177421	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	27049736362	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27049736362	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	324412	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	270497	usd
CY2023Q2	bomo	Common Stock To Be Issued CommonStockToBeIssued	2550000	usd
CY2022Q4	bomo	Common Stock To Be Issued CommonStockToBeIssued	2550000	usd
CY2023Q2	bomo	Common Stock Value Yet To Be Issued CommonStockValueYetToBeIssued	26	usd
CY2022Q4	bomo	Common Stock Value Yet To Be Issued CommonStockValueYetToBeIssued	26	usd
CY2023Q2	bomo	Treasury Stock Share TreasuryStockShare	2917	shares
CY2022Q4	bomo	Treasury Stock Share TreasuryStockShare	2917	shares
CY2023Q2	us-gaap	Treasury Stock Value TreasuryStockValue	773500	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	773500	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4151380	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3599032	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9892011	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9243925	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-5938485	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-5896662	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	78603	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	183503	usd
	us-gaap	Revenues Revenues	4476	usd
	us-gaap	Revenues Revenues	149848	usd
CY2022Q2	us-gaap	Revenues Revenues	61181	usd
	us-gaap	Cost Of Revenue CostOfRevenue	48470	usd
CY2022Q2	us-gaap	Cost Of Revenue CostOfRevenue	20891	usd
	us-gaap	Gross Profit GrossProfit	4476	usd
	us-gaap	Gross Profit GrossProfit	101378	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	40290	usd
	us-gaap	Salaries And Wages SalariesAndWages	222119	usd
	us-gaap	Salaries And Wages SalariesAndWages	203285	usd
CY2023Q2	us-gaap	Salaries And Wages SalariesAndWages	100805	usd
CY2022Q2	us-gaap	Salaries And Wages SalariesAndWages	101017	usd
	bomo	Consulting Expense ConsultingExpense	60000	usd
	bomo	Consulting Expense ConsultingExpense	46667	usd
CY2023Q2	bomo	Consulting Expense ConsultingExpense	30000	usd
CY2022Q2	bomo	Consulting Expense ConsultingExpense	46667	usd
	us-gaap	Professional Fees ProfessionalFees	163469	usd
	us-gaap	Professional Fees ProfessionalFees	130718	usd
CY2023Q2	us-gaap	Professional Fees ProfessionalFees	3415	usd
CY2022Q2	us-gaap	Professional Fees ProfessionalFees	120718	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	107421	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	54915	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	30840	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	48588	usd
	us-gaap	Operating Expenses OperatingExpenses	553009	usd
	us-gaap	Operating Expenses OperatingExpenses	435585	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	165060	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	316990	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-548533	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-334207	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-165060	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-276700	usd
	us-gaap	Interest Expense InterestExpense	497405	usd
	us-gaap	Interest Expense InterestExpense	43160	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	227905	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	38150	usd
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	27856	usd
CY2022Q2	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	27856	usd
	bomo	Initial Recognition Of Derivative Liability InitialRecognitionOfDerivativeLiability	32429	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	430281	usd
	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-1545	usd
CY2023Q2	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-872763	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-99553	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16849	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1100668	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10294	usd
	us-gaap	Net Income Loss NetIncomeLoss	-648086	usd
	us-gaap	Net Income Loss NetIncomeLoss	-351056	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1265728	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-286994	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	30223358741	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3392972124	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32265168504	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6730708291	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-842294	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-64062	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-906356	usd
CY2022Q2	bomo	Recapitalization At Reverse Merger RecapitalizationAtReverseMerger	-3082418	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	306220	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	599119	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-286994	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-3370429	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-5896662	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	28314	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	14995	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	418587	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	617642	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-4817124	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	28314	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	9994	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	106059	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1265728	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-5938485	usd
	us-gaap	Profit Loss ProfitLoss	-648086	usd
	us-gaap	Profit Loss ProfitLoss	-265917	usd
	bomo	Reconciliation Of Debt Balances ReconciliationOfDebtBalances	60000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-430281	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	17820	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	442550	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	42457	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	154628	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	50	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	91035	usd
	bomo	Grant Income GrantIncome	6000	usd
	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	20490	usd
	bomo	Initial Derivative Expense InitialDerivativeExpense	32429	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-15543	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	37638	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	139483	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	13970	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-287	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	14380	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-8128	usd
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	133281	usd
	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	309079	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	3108	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-88378	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	274	usd
	bomo	Payments Of Loans Payable PaymentsOfLoansPayable	980	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-980	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-89358	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	274	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	167103	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	111	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	77745	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	385	usd
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3392972124	shares
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Use of Estimates</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i><span style="text-decoration:underline">Concentrations of Credit Risk</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash.</p>
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6730708291	shares
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	61181	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	4476	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	149848	usd
CY2022Q4	us-gaap	Loans Receivable Basis Spread On Variable Rate LoansReceivableBasisSpreadOnVariableRate	1	pure
CY2023Q2	bomo	Revenues Percentage RevenuesPercentage	1	pure
	bomo	Revenues Percentage RevenuesPercentage	1	pure
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	27856	usd
CY2023Q2	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	9890000	usd
CY2022Q4	bomo	Asset Acquisition Additional Equity Interest Issued And Issuable AssetAcquisitionAdditionalEquityInterestIssuedAndIssuable	1000000000	shares
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	197370	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	21862	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	15279	usd
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	bomo	Reconciliation Of Debt Balances ReconciliationOfDebtBalances		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q2	us-gaap	Other Loans Payable OtherLoansPayable	564000	usd
CY2022Q4	us-gaap	Other Loans Payable OtherLoansPayable	564000	usd
CY2023Q2	bomo	Debt Instrument Carrying Amounts DebtInstrumentCarryingAmounts	920681	usd
CY2022Q4	bomo	Debt Instrument Carrying Amounts DebtInstrumentCarryingAmounts	1197681	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	-145540	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	-528100	usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	775141	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	669581	usd
	us-gaap	Premiums Earned Net PremiumsEarnedNet	920681	usd
CY2023Q2	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	179684	usd
CY2021Q4	us-gaap	Derivative Instruments And Hedges Liabilities DerivativeInstrumentsAndHedgesLiabilities	110992	usd
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	2718645	usd
CY2022	bomo	Derivative Liability Transfer To Put Premium DerivativeLiabilityTransferToPutPremium	-112537	usd
CY2022	bomo	Derivative Gain Loss On Derivative Fair Value DerivativeGainLossOnDerivativeFairValue	-544850	usd
CY2022Q4	us-gaap	Derivative Instruments And Hedges Liabilities DerivativeInstrumentsAndHedgesLiabilities	2172250	usd
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	129929	usd
	bomo	Derivative Liability Transfer To Put Premium DerivativeLiabilityTransferToPutPremium	-62338	usd
	bomo	Derivative Gain Loss On Derivative Fair Value DerivativeGainLossOnDerivativeFairValue	-430442	usd
CY2023Q2	us-gaap	Derivative Instruments And Hedges Liabilities DerivativeInstrumentsAndHedgesLiabilities	1809399	usd
	bomo	Grant Income GrantIncome		usd
	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount		usd
	bomo	Initial Derivative Expense InitialDerivativeExpense		usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000000	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	27049736362	shares
CY2023Q2	us-gaap	Stockholders Equity Other Shares StockholdersEquityOtherShares	1144057959	shares
	us-gaap	Stockholders Equity Other Shares StockholdersEquityOtherShares	5391441059	shares
CY2023Q2	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	5391441059	shares
CY2023Q2	bomo	Debt Instrument Face Value DebtInstrumentFaceValue	375000	usd
	us-gaap	Debt Instrument Increase Decrease Other Net DebtInstrumentIncreaseDecreaseOtherNet	29152	usd
CY2023Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	20490	usd
CY2023Q2	bomo	Total Debt Current TotalDebtCurrent	424642	usd
CY2022Q4	bomo	Share Available To Purchase With Stock Warrants Outstanding Number ShareAvailableToPurchaseWithStockWarrantsOutstandingNumber	5616000000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.0001
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	6.09
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	500000000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.0001
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	4.72
CY2023Q2	bomo	Share Available To Purchase With Stock Warrants Outstanding Number ShareAvailableToPurchaseWithStockWarrantsOutstandingNumber	6116000000	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.0001
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5.14
CY2023Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	6116000000	shares
	bomo	Weighted Average Price Exercisable WeightedAveragePriceExercisable	0.0001
	bomo	Weighted Average Fair Value Exercisable Outstanding WeightedAverageFairValueExercisableOutstanding	5.14
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet		usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
	bomo	Payments Of Loans Payable PaymentsOfLoansPayable		usd
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6116000000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P5Y10M9D
	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	0.0001
CY2022	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	40875	usd
CY2021	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	50500	usd
	bomo	Amount Of Indebtedness AmountOfIndebtedness	1200000	usd
CY2017Q1	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	27084	usd
CY2023Q2	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	10000	usd
	bomo	Total Principal Amount TotalPrincipalAmount	20000	usd
CY2023Q2	us-gaap	Revenues Revenues		usd
CY2023Q2	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023Q2	us-gaap	Gross Profit GrossProfit		usd
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt		usd
CY2023Q2	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt		usd
CY2023Q2	bomo	Initial Recognition Of Derivative Liability InitialRecognitionOfDerivativeLiability		usd
CY2022Q2	bomo	Initial Recognition Of Derivative Liability InitialRecognitionOfDerivativeLiability		usd
CY2022Q2	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives		usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax		usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	bomo	Weighted Average Price Forfeited WeightedAveragePriceForfeited
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
	bomo	Weighted Average Fair Value Expired WeightedAverageFairValueExpired
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0001381871

Files In Submission

Name	View Source	Status
0001213900-23-071846-index-headers.html	Edgar Link	pending
0001213900-23-071846-index.html	Edgar Link	pending
0001213900-23-071846.txt	Edgar Link	pending
0001213900-23-071846-xbrl.zip	Edgar Link	pending
bomo-20230630.xsd	Edgar Link	pending
f10q0623ex31_bowmoinc.htm	Edgar Link	pending
f10q0623ex32_bowmoinc.htm	Edgar Link	pending
f10q0623_bowmoinc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
bomo-20230630_lab.xml	Edgar Link	unprocessable
bomo-20230630_def.xml	Edgar Link	unprocessable
bomo-20230630_cal.xml	Edgar Link	unprocessable
bomo-20230630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10q0623_bowmoinc_htm.xml	Edgar Link	completed
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BOMO
bowmo, Inc. Stock $bomo

2023 Q3 Form 10-Q Financial Statement

#000121390023071846 Filed on August 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BOMO bowmo, Inc. Stock $bomo

2023 Q3 Form 10-Q Financial Statement

#000121390023071846 Filed on August 30, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BOMO
bowmo, Inc. Stock $bomo